April 13, 2016
4 min watch
Save

VIDEO: Pituitary dysfunction after traumatic brain injury may be an uncharacterized chronic disease

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

BOSTON — In this video exclusive, Tamara Wexler, MD, PhD, director of the Pituitary Center at New York University Langone Medical Center, gives her perspective on current research into traumatic brain injury.

Wexler highlights a study presented by Randall J. Urban, FACP, MD, and Melinda Sheffield-Moore, PhD, about chronic pituitary effects following TBI and the possible benefits of growth hormone therapy on fatigue and cognitive dysfunction. The researchers are approaching this condition as a previously uncharacterized chronic disease.

Further investigation into the prevalence and time course of pituitary deficiencies, as well as the impact of replacement in this specific patient population are needed, according to Wexler. “The area is ripe for further study on what types of patients with concussion tend to develop pituitary deficiency.”